Novel endoscopic technique for trisegment drainage in patients with unresectable hilar malignant biliary strictures (with video) - 21/08/20
Abstract |
Background and Aims |
Three or more stents may be needed in patients with extensive stricturing in Bismuth type IIIa/IV hilar malignant strictures. Partial stent-in-stent (PSIS) deployment has been the primary intervention for hilar malignant biliary stricture (MBS). However, simultaneous side-by-side (SBS) stent placement has become feasible with the development of the <6F diameter stent delivery system. Our aim was to assess the efficacy and safety of a new hybrid method combining PSIS and SBS stent placement for trisegment biliary drainage.
Methods |
This study included 17 consecutive patients with Bismuth IIIa or IV malignant strictures who underwent endoscopic drainage using the hybrid method. Diameters of the delivery stents were 5.4F (n = 10) and 5.7F (n = 7).
Results |
The technical success rate was 82% (14/17), and the median length of procedures was 54 minutes. Two patients required predilatation for deployment of the third self-expandable metallic stent through the mesh of the first deployed stent. Two patients (12%) developed cholecystitis as early adverse events, and 1 patient (6%) developed liver abscess as a late adverse event. The time to recurrent biliary obstruction among those with successful initial trisegmental drainage was 189 days (95% confidence interval, 124-254).
Conclusions |
The hybrid method for unresectable hilar MBS is an effective endoscopic drainage method, and the ease of these procedures is partly attributed to the thinner stent delivery system.
Le texte complet de cet article est disponible en PDF.Abbreviations : MBS, PSIS, SBS, SEMS, TRBO
Plan
| DISCLOSURE: All authors disclosed no financial relationships. This work was supported in part by The National Cancer Center Research and Development Fund 31-A-13 and JFE (The Japanese Foundation for Research and Promotion of Endoscopy) Grant. |
|
| If you would like to chat with an author of this article, you may contact Dr Hijioka at rizasusu@gmail.com. |
Vol 92 - N° 3
P. 763-769 - septembre 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
